Teneligliptin Hydrobromide Hydrate
Composition
The formulation contains Teneligliptin Hydrobromide Hydrate as the active ingredient.
Indications
Type 2 diabetes mellitus
Side effects
Hypoglycemia, GI upset
Precautions
Monitor renal function and blood glucose levels regularly.
Contraindications
Type 1 diabetes, diabetic ketoacidosis, hypersensitivity
Dosage and administration
As directed by healthcare provider
Countries
Japan
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai